Supporting and Maintaining a Surveillance System for Chronic Kidney Disease (CKD) in the United States

Chronic Kidney Disease (CKD)
CFDA 93.833 Active Cooperative Agreement

Program Funding

Annual program obligations reported to SAM.gov.

Latest annual funding (estimated)
$1.2M FY2026
$1.2M
FY24
$1.2M
FY25
$1.2M
FY26*
* estimated

Program Objective

This program will build upon previous work to continue developing, supporting and enhancing the Chronic Kidney Disease (CKD) Surveillance System in the United States, to monitor the burden and trends of CKD and its risk factors over time, and monitor and evaluate trends in achieving Healthy People 2030 objectives.

Eligibility

Eligible Applicants

  • U.S. State Government
  • Nonprofit Organization
  • Federally Recognized Tribal Government
  • U.S. Territory Government

• Public nonprofit organizations
• Private nonprofit organizations
• For profit organizations
• Small, minority, and women-owned businesses
• Universities
• Colleges
• Research institutions
• Hospitals
• Community-based organizations
• Faith-based organizations
• Indian/Native American Tribal Governments (Federally Recognized)
• Indian/Native American Tribal Governments (other than Federally recognized)
• Indian/Native American Tribally Designated Organizations

State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). Note: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application.

Beneficiaries

  • Specific Restrictions (Determined at NOFO Level)

The general public will benefit from the objectives of this program. Kidney diseases are the ninth leading cause of death in the United States and more than 1 of 10 US adults may have Chronic Kidney Disease (CKD). The CKD Surveillance System is intended to raise awareness about CKD and its risk factors, promote early diagnosis, and improve outcomes for those living with CKD.

How to Apply

Award Procedure

After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.

Decision Timeline

  • Approval: From 120 to 180 days
  • Renewal interval: From 90 to 120 days

Eligible applicants must be able to demonstrate: -Previous experience with the development of large-scale Chronic Kidney Disease (CKD) surveillance systems -Established and current data sharing and access agreements with appropriate federal, public and private partners for access to data relevant to the CKD surveillance system -A proven track record of publications related to the establishment of a national CKD surveillance system and dissemination of surveillance findings. -Previous experience with national, regional, and hospital based data pertaining to CKD and its risk factors -Previous experience with working in a collaborative multi-center project for the development and maintenance of a national surveillance system.

Program details & compliance

Description

This program will build upon previous work to continue developing, supporting and enhancing the Chronic Kidney Disease (CKD) Surveillance System in the United States, to monitor the burden and trends of CKD and its risk factors over time, and monitor and evaluate trends in achieving Healthy People 2030 objectives.

Mission Categories

Primary: Prevention and Control (includes Suicide Prevention)

Other categories:
General Health and Medical

Use of Funds

Allowed Uses

Applicants must adhere to all Centers for Disease Control and Prevention (CDC) guidelines regarding allowable and unallowable expenses.
Maintain and enhance a viable and functional Chronic Kidney Disease (CKD) Surveillance System website - www.cdc.gov/ckd/surveillance.
Increase the visibility of the CKD Surveillance System and disseminate the CKD surveillance findings by the number of publications and related citations in peer-reviewed journals and presentations at national and international meetings and conferences.
Improve the breadth and scope of CKD surveillance data in the United States by the number of established and current data sharing and access agreements with appropriate federal, public and private partners for access to data relevant to CKD surveillance.
Expand and grow the CKD Surveillance System by the number of CKD topics and indicators focusing on CKD burden and health consequences, risk factors, at-risk or vulnerable populations, and geographic indicators with up-to-date data and trends.
Assess and evaluate the CKD Surveillance System content, data sources to keep or include, gaps in surveillance data, and future data and research needs.
Provide data analysis reports for Healthy People 2030 progress review in achieving CKD objectives.

Restrictions

Restrictions, which must be taken into account while writing the budget, are as follows: •Recipients may not use funds for research. •Recipients may not use funds for clinical care. •Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. •Awardees may not generally use U.S. Department of Health and Human Services (HHS)/ Centers for Disease Control and Prevention (CDC)/ Agency for Toxic Substances and Disease Registry (ATSDR) funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget. •The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible. •Reimbursement of pre-award costs is not allowed.

Required Documentation

Any required credentials and/or documentation will be identified in the specific Notice of Funding Opportunity (NOFO) for this Assistance Listing.

Reporting & Compliance

Records Retention
3 years

Applicable 2 CFR 200 Subparts

  • Subpart B — General Provisions
  • Subpart C — Pre-Federal Award Requirements
  • Subpart D — Post-Federal Award Requirements
  • Subpart E — Cost Principles
  • Subpart F — Audit Requirements

Contacts

LaShanda Washington
770-488-2766
4770 Buford Hwy, NE, Atlanta, GA 30341
Data from SAM.gov Federal Assistance Listings. Source published: 2026-01-12. Spec v2.0. Last synced: 2026-05-30 02:36:51.